Schizophrenia Research
Volume 45, Issue 3 , Pages 223-234 , 27 October 2000

Attitudes towards neuroleptic treatment: Reliability and validity of the Attitudes towards Neuroleptic Treatment (ANT) questionnaire

Received 8 March 1999 ,Accepted 15 October 1999.

References 

  1. Adams SG, Howe JT. Predicting medication compliance in a psychotic population. J. Nerv. Ment. Dis. 1993;181:558–560
  2. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am. J. Psychiat. 1993;150:873–879
  3. Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr. Bull. 1993;19:609–618
  4. Babiker IE. Noncompliance in schizophrenia. Psychiatr. Dev. 1986;4:329–337
  5. Bebbington P, Kuipers L. The predictive utility of expressed emotion in schizophrenia: An aggregate analysis. Psychol. Med. 1994;24:707–718
  6. Cuesta MJ, Peralta V, Caro F, de-Leon J. Is poor insight in psychotic disorders associated with poor performance on the Wisconsin Card Sorting Test?. Am. J. Psychiatry. 1995;152:1380–1382
  7. David AS. Insight and psychosis. Br. J. Psychiatry. 1990;156:798–808
  8. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br. J. Psychiatry. 1992;161:599–602
  9. Falloon IR. Developing and maintaining adherence to long-term drug-taking regimens. Schizophr. Bull. 1984;10:412–417
  10. Fennig S, Everett E, Bromet EJ, Jandorf L, Fennig SR, Tanenberg-Karant M, et al. Insight in first-admission psychotic patients. Schizophr. Res. 1996;22:257–263
  11. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 1997;23:637–651
  12. Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania. 1. Specifying a mechanism. Arch. Gen. Psychiatry. 1994;51:939–944
  13. Green MF. What are the functional consequenses of neurocognitive deficits in schizophrenia?. Am. J. Psychiat. 1996;153:321–330
  14. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983;13:177–183
  15. Kane JM. Problems of compliance in the outpatient treatment of schizophrenia. J. Clin. Psychiatry. 1983;44:3–6
  16. Kay SR, Opler LA, Fiszbein A. Positive and Negative Symptom Scale (PANSS). Rating Manual. 1987;
  17. Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br. J. Psychiatry. 1996;169:444–450
  18. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. Br. Med. J. 1996;312:345–349
  19. Lysaker P, Bell M, Milstein R, Bryson G, Beamgoulet J. Insight and psychosocial treatment compliance in schizophrenia. Psychiatry Interp. Biol. Proc. 1994;57:307–315
  20. Macpherson R, Jerrom B, Hughes A. Relationship between insight, educational background and cognition in schizophrenia. Br. J. Psychiatry. 1996;168:718–722
  21. McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, et al. Insight in schizophrenia. Its relationship to acute psychopathology. J. Nerv. Ment. Dis. 1989;177:43–47
  22. Mantonakis J, Markidis M, Kontaxakis V, Liakos A. A scale for detection of negative attitudes towards medication among relatives of schizophrenic patients. Acta Psychiatr. Scand. 1985;71:186–189
  23. Naber D. A self-rating to measure subjective effects of neuroleptic drugs relationships to objective psychopathology quality of life compliance and other clinical variables. Int. Clin. Psychopharmacol. 1995;10(3):133–138
  24. Naber D. Subjective experiences of schizophrenic patients treated with antipsychotic medication. Int. Clin. Psychopharmacol. 1998;13(1):41–45
  25. Nuechterlein KH, Dawson ME, Green MF. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatr. Scand. 1994;90:71–79
  26. Sackett DL, Haynes BR. Compliance with Therapeutic Regimens. Baltimore, MD: The Johns Hopkins University Press; 1976;
  27. Van-Putten T. Drug refusal in schizophrenia: causes and prescribing hints. Hosp. Commun. Psychiatr. 1978;29:110–112
  28. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr. Bull. 1994;20:297–310

PII: S0920-9964(99)00204-2

Schizophrenia Research
Volume 45, Issue 3 , Pages 223-234 , 27 October 2000

Article Tools

* Image Usage & Resolution